Walgreens now has certified more than 500 of its pharmacies as HIV Centers of Excellence in communities highly impacted by HIV, as identified by the Centers for Disease Control and Prevention, the pharmacy operator announced Thursday at the U.S. Conference on AIDS.
CVS Caremark’s MinuteClinic has prepared all of its Texas-based clinics for an increased demand for the meningococcal vaccine for bacterial meningitis following a bill signed into law last May, whereby Texas will become the first state in the country to require that all college students receive one dose or booster of the meningococcal vaccine for bacterial meningitis.
The Magic Johnson Foundation on Monday initiated Point Forward Day, marking 20 years to the date that Johnson announced his HIV status and subsequent retirement from the National Basketball Association.
New York City mayor Michael Bloomberg and health commissioner Thomas Farley received their seasonal flu vaccine on Saturday at a Duane Reade pharmacy in the Bronx, demonstrating the importance of taking steps to prevent the spread of the virus.
This year’s jump in measles in the United States and Canada was costly and occurred among unvaccinated children and adults, suggested several studies being presented at the 49th Annual Meeting of the Infectious Diseases Society of America here Thursday.
Sanofi Pasteur, the vaccines division of Sanofi, released data from a new study examining the ability of its Fluzone High-Dose vaccine to provoke an immune response in elderly and younger adults, compared with a standard dose of Fluzone vaccine.
On average, 20,000 children under the age of 5 years are hospitalized due to flu symptoms each year, the Loyola University Health System announced Thursday in a press release encouraging parents to have their children inoculated.
At the beginning of the year, a major global controversy was settled when it turned out that a study published in The Lancet in 1998 linking the measles-mumps-rubella vaccine to autism in children turned out to be a whopper of a fraud.
Drug makers have 901 biotech drugs under development for more than 100 diseases ranging from cancers and infectious diseases to autoimmune disorders and cardiovascular diseases, the Pharmaceutical Research and Manufacturers of America said.